Maymufa Company, Ltd. was established in 1976. The company specializes in oriental hair care product and researches, develops, manufactures and markets products under its own brand name “ Maywufa”.

The company has since expanded and diversified into pharmaceutical related business, and in 1998, ventured into new drug development business by funding PhytoHealth Corporation. Both Maywufa and PhytoHealth are public companies listed on the Taiwan Stock Exchange in the category of biotech.

 

Maywufa’s business consists of four strategic business divisions including Haircare & Skincare Division, Pharmacy Franchise/GP&AH Division, Kaisers Medical Division and Institutional Hospitals Division.

 

Over the last several years, Haircare & Skincare Division has consecutively been awarded the “Gold Award” and the “Platinum Award” in the appraisal of Trusted Brand by Readers’ Digest. In addition, it has also won many other awards including “Taiwan Excellence Award”, National Biotechnology and Medical Care Quality Award” and  “Symbol of National Quality”.

E-ICP market survey indicates that one out of two users selects Maywufa colorants for gray hair coverage in Taiwan. AC Nielsen survey, on the other hand, reveals that 62% of hair colorant users would designate “Maywufa Brand” products.

 

Pharmacy Franchise/GP&AH Division operates the largest pharmacy franchise system in Taiwan specialized in dispensing of prescription drugs with more than 200 pharmacy stores accredited by the Department of Health. The Division also has full range coverage of sales channels for pharmaceutical products. Its sales network covers more than 5000 drug stores, GPs and hospitals in Taiwan.

 

Kaisers Medical Division acts as the exclusive distributor or agent for many renowned  pharmaceutical ,cosmeceutical and cosmetic companies, including Novo Nordisk, a world leader in anti-diabetics products, French cosmeceutical brands-Mustela and Noviderm, Japanese cosmetic brand-Mariannebolle and European pharmaceutical companies-Novartis, Ever Neuro, Nasaleze and BioEqual and Neomedis… etc.

 

Institutional Hospitals Division is dedicated to the sales and marketing of pharmaceutical products to major institutional hospitals in Taiwan. Under the model of “ R&D by PhytoHealth, sales and marketing by Maywufa, this division is responsible for the sales and marketing of PhytoHealth’s products, including PG2 injection for the indication of cancer related fatigue, Epilen for for the indication of epilepsy and other nutraceutical products such as PhytoSlim for less easy formation of body fat, Nattokinase Extract capsule and Red Yeast Rice product for lipid lowering and Bio-Three H for gastrointestinal tract care.